KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Short-term Investments (2020 - 2025)

CareDx's Short-term Investments history spans 6 years, with the latest figure at $111.8 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 23.42% year-over-year to $111.8 million; the TTM value through Dec 2025 reached $111.8 million, down 23.42%, while the annual FY2025 figure was $111.8 million, 23.42% down from the prior year.
  • Short-term Investments for Q4 2025 was $111.8 million at CareDx, up from $102.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $211.3 million in Q1 2023 and bottomed at $10.2 million in Q3 2021.
  • The 5-year median for Short-term Investments is $142.2 million (2025), against an average of $135.9 million.
  • The largest annual shift saw Short-term Investments skyrocketed 1942.52% in 2022 before it plummeted 41.96% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $10.2 million in 2021, then soared by 1892.04% to $203.2 million in 2022, then dropped by 24.58% to $153.2 million in 2023, then dropped by 4.74% to $146.0 million in 2024, then fell by 23.42% to $111.8 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Short-term Investments are $111.8 million (Q4 2025), $102.8 million (Q3 2025), and $118.0 million (Q2 2025).